Long-term renal allograft survival in the United States: a critical reappraisal. - Wikidata - awgldk - TriplyDB

Long-term renal allograft survival in the United States: a critical reappraisal.

Long-term renal allograft survival in the United States: a critical reappraisal.

http://www.wikidata.org/entity/Q39824383

about

Metabolic consequences of modern immunosuppressive agents in solid organ transplantation Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation Computational Biology: Modeling Chronic Renal Allograft Injury Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism Pediatric priority in kidney allocation: challenging its acceptability Factors influencing long-term outcome after kidney transplantation Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events Regulatory B cells: an exciting target for future therapeutics in transplantation Proteomics and metabolomics in renal transplantation-quo vadis?Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rγnull mice Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence Does belatacept improve outcomes for kidney transplant recipients? A systematic review The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation The Spectrum of Renal Allograft Failure The future direction and unmet needs of transplant immunosuppression.Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy.Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial Clinical and economic outcomes associated with medication errors in kidney transplantation Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial Graft Function and Intermediate-Term Outcomes of Kidney Transplants Improved in the Last Decade: Analysis of the United States Kidney Transplant Database.Dialysis patients refusing kidney transplantation: data from the Slovenian Renal Replacement Therapy Registry.Kidney transplant survival in pediatric and young adults Costimulatory pathways in transplantation.Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study.Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients Comprehensive investigation of the caveolin 2 gene: resequencing and association for kidney transplant outcomes Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.Risk-adjusted analysis of relevant outcome drivers for patients after more than two kidney transplants.Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis.Assessment of the relationship between ACE I/D gene polymorphism and renal allograft survival.A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.Chronic bile duct hyperplasia is a chronic graft dysfunction following liver transplantation.

P2860

Q26746936-53D91CC3-A0F0-4E41-AE65-8F653BDC29A2 Q26767458-939120A1-A812-4B11-9699-B3ADBDF43CB9 Q26797336-5CB02720-13BA-4D94-94C8-58EC59286185 Q26799916-510E46AB-5DB7-44DF-AE43-5F5D6B5AA726 Q26801029-F4E72837-C218-4392-9E17-ED1525872B1D Q26825138-F321C537-A839-4BB5-856F-08B06AC2A50D Q26825480-6A9E44E0-EC17-4EE2-88CA-4EB5AF9D0545 Q26866295-B9EFCEDC-249C-48EE-901B-2ADB6D489A2B Q27015093-7E9AB9DD-E256-4BED-9348-08BD978EF6CD Q27024418-70D48BB5-1FF1-4514-8861-22BEC08D8508 Q27318356-F9CC4F77-5193-4F14-91E6-AAD90525B76B Q28079089-22BD64C0-5FE1-4F18-8BD0-A5FBA22F03AA Q28084644-B366D140-B4F2-480E-9193-59523C1BB730 Q28085440-B5E86E9F-25E5-4747-B2DA-0CA1B8D60579 Q28554254-A2FE4B18-E5F6-46D4-B26D-7DFF60B86DE7 Q30277037-7167D10F-DADE-43A0-ABEB-DC35292FB132 Q30362814-74C8B8C8-633F-437C-BC1E-782F7FE5A4F2 Q33439981-39002D46-914C-48AE-9018-A4A7F84515D8 Q33571836-F912909C-0A7E-4537-868E-D969F7B86B65 Q33584895-DCF6B8A7-648C-470D-9AED-331FEDAFA811 Q33779071-0E51901F-377C-4F23-A034-5D8B34DF4051 Q33915604-D463C42E-0299-414A-9158-96A0B92FFEB9 Q34044051-EE45628B-517B-4AE5-A996-ED54C172C5B8 Q34187594-9DF02FCE-0C7B-4175-9026-746895CFDC1C Q34412887-3AB6DC7E-BF81-4DA6-BBEC-A3A89BD81774 Q34483895-0D1CAA76-A0F5-4211-A897-8BCAC9E0A875 Q34556614-19C800E1-1A53-47D9-ACDF-8E6176750472 Q34718127-CD58C06D-182E-46F4-82C8-7CB8A6AAD9A5 Q34753440-1D5B1C19-DE66-4F62-A7B4-4680DC8D7325 Q34841849-57139B28-84E1-4B03-AFDE-1D86EC57083E Q35027253-9B299BF6-9469-49AB-B883-CACBD9C5C2E4 Q35078258-8D3F0102-3638-4592-BE9B-665A37F7B08C Q35083760-43D9828D-B3F9-4EE2-BC95-8E681C2C019C Q35097835-B3CCEA78-3C5B-4A53-A0B1-C4408C27E76C Q35177040-58E63F04-F7A9-4883-892F-2E12E1069253 Q35242533-05A81ED5-ADE2-4810-A6C6-5C28BB50A514 Q35580192-524C9737-71D6-4715-853C-4258F27A4BBB Q35649082-26E5835E-7239-4529-8459-E27F03B2C2D8 Q35790552-FD87A770-EA5C-4C4B-86EC-5EDC3CA13D71 Q35813190-77994CC8-A573-4678-964B-2C51B0D90E63

P2860

Long-term renal allograft survival in the United States: a critical reappraisal.

http://www.wikidata.org/entity/Q39824383

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Long-term renal allograft survival in the United States: a critical reappraisal.

@en

Long-term renal allograft survival in the United States: a critical reappraisal.

@nl

type

label

Long-term renal allograft survival in the United States: a critical reappraisal.

@en

Long-term renal allograft survival in the United States: a critical reappraisal.

@nl

prefLabel

Long-term renal allograft survival in the United States: a critical reappraisal.

@en

Long-term renal allograft survival in the United States: a critical reappraisal.

@nl

P1433

Q39824383-3C65977D-0F1B-4A7D-8987-848C6A0985D8

P1476

Q39824383-81729CD8-8DB7-4100-82B1-01BDC6669B59

P2093

Q39824383-A3C89B13-DFFA-4A97-BCF1-AFAB2BB607E4

Q39824383-D65E8313-0133-4575-AFBF-E5DC236F768E

Q39824383-ED462885-9E8C-4C82-A50A-BF65DA708F90

P2860

Q39824383-09AED81F-953B-4954-BF15-BEDFD6656239

Q39824383-1DD30754-30FE-4136-B5F8-69832B8B6A4F

Q39824383-2668F5F3-CAB2-4112-AB5C-717564ECCEDC

Q39824383-2D8404D1-DE5D-445C-BB53-83E5198AB941

Q39824383-AA2740D0-7055-4456-9331-DD3A9C07600F

Q39824383-B3501C4C-5942-4EBC-801F-106E9A170937

Q39824383-F22BE036-D668-4B80-90F0-46E2A3ED6490

Q39824383-F7A531DB-EEB8-4806-B3FF-EE8DD91732D9

P304

Q39824383-A2090F93-B289-4DB6-9008-9BAD226578BB

P31

Q39824383-6033B588-32E2-41B7-B58A-96B2C8728161

P356

Q39824383-B5A6E212-D2D2-4CB0-967C-E5963DC475E5

P407

Q39824383-AFDC7EF9-B644-4080-8EF6-B42A0914CEFB

P433

Q39824383-7C36CD00-B16B-4D47-ABD5-DE3C72D5B240

P478

Q39824383-BFE7C93E-0042-405C-8B2F-AE30988860CB

P577

Q39824383-9ACAD1BC-E061-4862-8839-ABF7A3612642

P5875

Q39824383-2B5F30A8-5BBF-46FB-BC8E-C90464A68D66

P698

Q39824383-6F8606A0-F4E7-433B-9803-B3E6D882EF7F

P921

Q39824383-C7B1B339-EE2E-4C66-B1BB-D10AF6E07926

P356

J.1600-6143.2010.03283.X

P1433

American Journal of Transplantation

P1476

Long-term renal allograft survival in the United States: a critical reappraisal.

@en

P2093

H-U Meier-Kriesche

http://www.w3.org/2001/XMLSchema#string

K E Lamb

http://www.w3.org/2001/XMLSchema#string

S Lodhi

http://www.w3.org/2001/XMLSchema#string

P2860

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.

Strategies to improve long-term outcomes after renal transplantation.

Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

Racial disparities in renal allograft survival: a public health issue?

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Death after graft loss: an important late study endpoint in kidney transplantation.

Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center.

P304

450-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2010.03283.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47543363

http://www.w3.org/2001/XMLSchema#string

P698

20973913

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq